Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. NIDA has developed two Avenir Award Programs, one for HIV/AIDS research and the other for genetics or epigenetics studies. The Genetics or Epigenetics of Substance Use Disorders Avenir Award program supports early stage investigators proposing highly innovative studies that open new areas of research for the genetics or epigenetics of addiction. These may be novel methods or approaches that can potentially be applied to the analysis of the genetics or epigenetics of addiction. Investigators outside the field of addiction interested in applying their novel approaches to the genetics or epigenetics of addiction are encouraged to apply. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field of genetics or epigenetics of substance use disorders.

Applicant and host information

Applicant citizenship: United States

Host country: United States

Years since PhD:

Award details

Award: $1 500 000

Award Duration (years): 5

Research costs:

Benefits:

Mobility rule:

Subjects: Life Sciences , Medicine and Health Sciences

Additional comments: Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. NIDA has developed two Avenir Award Programs, one for HIV/AIDS research and the other for genetics or epigenetics studies. The Genetics or Epigenetics of Substance Abuse Avenir Award program supports early stage investigators proposing highly innovative studies that open new areas of research for the genetics or epigenetics of addiction. These may be novel methods or approaches that can potentially be applied to the analysis of the genetics or epigenetics of addiction. Investigators outside the field of addiction interested in applying their novel approaches to the genetics or epigenetics of addiction are encouraged to apply. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field of genetics or epigenetics. Application budgets are limited to $300,000 in Direct Costs each year for five years, plus applicable Facilities and Administrative (F&A) costs to be determined at the time of award ($1,500,000 max over 5 years).

How to apply? For further eligibility requirements and the application process, please visit: Official Funding website


Share this funding

Application deadline

October 19, 2017; October 19, 2018
We make ensure the accuracy, please refer to the official website for complete details.
Note: This is a community curated project, please contribute/report if any information is missing or not correct. We highly appreciate your contributions!

This entry has been last updated: 2020-05-24 13:36:15

© 2020 ECRcentral. The content is licensed under Creative Commons BY 4.0.
ECRcentral is developed with by eLife Ambassadors.